Pharmaceutical preparations for intranasal administration

Details Pharmaceutical preparations for intranasal administration Pharmaceutical preparations for intranasal administration

1997-09-03

1999-09-07

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 424489, 424499, 424501, A61K 3800

Patent

active

059487496

ABSTRACT:
A pharmaceutical preparation for intranasal administration having a better absorption rate and less irritant effects is provided. The pharmaceutical preparation comprises a mixture of a powder of an adsorbent resin and a biologically active peptide having a drug effect under the condition that they are dry prior to or after the mixing.

REFERENCES:
patent: 4250163 (1981-02-01), Nagai
patent: 5112804 (1992-05-01), Kowarski
patent: 5158761 (1992-10-01), Kamishita
patent: 5204108 (1993-04-01), Illum
patent: 5342922 (1994-08-01), Marshall
patent: 5397771 (1995-03-01), Bechgaard
patent: 5554388 (1996-09-01), Illum
patent: 5604257 (1997-02-01), Tabe
patent: 5675031 (1997-10-01), Furuya

Affiliated with

Also associated with

Rating

Pharmaceutical preparations for intranasal administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical preparations for intranasal administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparations for intranasal administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1804543